M. Abrahamowicz

First name

M.

Last name

Abrahamowicz

Movahedi, M., Beauchamp, M. E., Abrahamowicz, M., Ray, D. W., Michaud, K., Pedro, S., & Dixon, W. G. (2016). Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. http://doi.org/10.1002/art.39537

View

Tamblyn, R., Girard, N., Dixon, W. G., Haas, J., Bates, D. W., Sheppard, T., et al. (2016). Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events. J Clin Epidemiol. http://doi.org/10.1016/j.jclinepi.2016.03.033

View

Sheppard, T., Tamblyn, R., Abrahamowicz, M., Lunt, M., Sperrin, M., & Dixon, W. G. (2017). A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4273

View

Joseph, R. M., van Staa, T. P., Lunt, M., Abrahamowicz, M., & Dixon, W. G. (2018). Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4649

View

Joseph, R. M., van Staa, T. P., Lunt, M., Abrahamowicz, M., & Dixon, W. G. (2019). Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4649

View